These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 12899739)

  • 21. When fluvoxamine treats only depression and clomipramine treats only obsessive-compulsive disorder--combine them?
    Schaller JL; Behar D; Chamberlain T
    J Neuropsychiatry Clin Neurosci; 1998; 10(1):111-3. PubMed ID: 9547477
    [No Abstract]   [Full Text] [Related]  

  • 22. Fluvoxamine photosensitivity.
    Gillet-Terver MN; Modiano P; Tréchot P; Barbaud A; Schmutz JL
    Australas J Dermatol; 1996 Feb; 37(1):62. PubMed ID: 8936079
    [No Abstract]   [Full Text] [Related]  

  • 23. Hair loss associated with fluvoxamine use.
    Parameshwar E
    Am J Psychiatry; 1996 Apr; 153(4):581-2. PubMed ID: 8599419
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug interaction of tizanidine and fluvoxamine.
    Momo K; Doki K; Hosono H; Homma M; Kohda Y
    Clin Pharmacol Ther; 2004 Nov; 76(5):509-10. PubMed ID: 15536467
    [No Abstract]   [Full Text] [Related]  

  • 25. Successful treatment of steroid-induced depression with low dosage of fluvoxamine.
    Yoshimura R; Ueda N; Nakamura J
    Aust N Z J Psychiatry; 2001 Dec; 35(6):855-6. PubMed ID: 11990900
    [No Abstract]   [Full Text] [Related]  

  • 26. Visual hallucinations and amnesia associated with zolpidem triggered by fluvoxamine: a possible interaction.
    Kito S; Koga Y
    Int Psychogeriatr; 2006 Dec; 18(4):749-51. PubMed ID: 17026779
    [No Abstract]   [Full Text] [Related]  

  • 27. An open-label pilot study of fluvoxamine for mixed anxiety-depression.
    Houck C
    Psychopharmacol Bull; 1998; 34(2):225-7. PubMed ID: 9641005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An interaction between carbamazepine and fluvoxamine.
    Martinelli V; Bocchetta A; Palmas AM; Del Zompo M
    Br J Clin Pharmacol; 1993 Dec; 36(6):615-6. PubMed ID: 12959283
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder.
    Volkers AC; Tulen JH; van den Broek WW; Bruyn JA; Passchier J; Pepplinkhuizen L
    Pharmacopsychiatry; 2004 Jan; 37(1):18-25. PubMed ID: 14750044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversible tremor and myoclonus associated with topiramate-fluvoxamine coadministration.
    Oulis P; Potagas C; Masdrakis VG; Thomopoulos Y; Kouzoupis AV; Soldatos CR
    Clin Neuropharmacol; 2008; 31(6):366-7. PubMed ID: 19050415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Digital infarction in a patient with Raynaud's phenomenon associated with treatment with a specific serotonin reuptake inhibitor. A case report.
    Bell C; Coupland N; Creamer P
    Angiology; 1996 Sep; 47(9):901-3. PubMed ID: 8810657
    [No Abstract]   [Full Text] [Related]  

  • 32. Augmentative effects of fluvoxamine on duloxetine plasma levels in depressed patients.
    Paulzen M; Finkelmeyer A; Grözinger M
    Pharmacopsychiatry; 2011 Nov; 44(7):317-23. PubMed ID: 21979923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single dose of fluvoxamine associated with an acute psychotic reaction.
    Sim FH; Massabki RA
    Can J Psychiatry; 2000 Oct; 45(8):762. PubMed ID: 11086561
    [No Abstract]   [Full Text] [Related]  

  • 34. [Fluvoxamine and serotonin syndrome in a patient with Parkinson disease].
    Le Cavorzin P; Sarkis S; Bénéton C; Pinel JF; Maruelle L; Le Vaou P; Allain H
    Therapie; 1996; 51(2):195-6. PubMed ID: 8763057
    [No Abstract]   [Full Text] [Related]  

  • 35. Suitable dose and duration of fluvoxamine administration to treat depression.
    Morishita S; Arita S
    Psychiatry Clin Neurosci; 2003 Apr; 57(2):177-81. PubMed ID: 12667164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluvoxamine-induced bullous eruption mimicking hand-foot syndrome and intertrigo-like eruption: rare cutaneous presentations and elusive pathogenesis.
    Ke CL; Chen CC; Lin CT; Chen GS; Chai CY; Cheng ST
    J Am Acad Dermatol; 2006 Aug; 55(2):355-6. PubMed ID: 16844531
    [No Abstract]   [Full Text] [Related]  

  • 37. Schneiderian first-rank symptoms associated with fluvoxamine treatment: a case report.
    Ueda N; Terao T; Ohmori O; Nakamura J
    Hum Psychopharmacol; 2003 Aug; 18(6):477-8. PubMed ID: 12923827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluvoxamine and celecoxib may have caused adverse events in an elderly patient.
    Hori K; Konishi K; Akita R; Tanaka H; Hachisu M
    Psychiatry Clin Neurosci; 2013 Jul; 67(5):363. PubMed ID: 23859666
    [No Abstract]   [Full Text] [Related]  

  • 39. Severe myoclonus produced by fluvoxamine.
    Bauer M
    J Clin Psychiatry; 1995 Dec; 56(12):589-90. PubMed ID: 8530337
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression.
    Otsubo T; Akimoto Y; Yamada H; Koda R; Aoyama H; Tanaka K; Mimura M; Nakagome K; Kamijima K
    Pharmacopsychiatry; 2005 Jan; 38(1):30-5. PubMed ID: 15706464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.